Skip to main content
. Author manuscript; available in PMC: 2019 Jun 22.
Published in final edited form as: Clin Pharmacol Ther. 2017 Dec 22:10.1002/cpt.997. doi: 10.1002/cpt.997

Table 3.

Parameter estimates obtained from the population pharmacokinetic model stratified by disease state.

Description of PK Parameter PK Parameter Healthy NASH Difference p-value
Uptake clearance from blood to liver CLuptake (L/min) 1.14
(0.732–2.27)
0.731
(0.382–1.04)
−0.398
[−0.679, −0.202]
0.0008*
Efflux clearance from liver to blood CLefflux (L/min) 0.00800
(0.00481–0.0139)
0.00579
(0.00475–0.00903)
−0.00192
[−0.00384, 0.000137]
0.0667
Clearance from liver to bile CLbile (L/min) 0.0354
(0.0157–0.0728)
0.0171
(0.0110–0.0207)
−0.0172
[−0.0268, −0.00467]
0.0005*
Uptake clearance from blood to the peripheral compartment CLuptake,peripheral (L/min) 0.754
(0.353–1.01)
0.491
(0.317–0.811)
−0.118
[−0.372, 0.0780]
0.322
Efflux clearance from the peripheral compartment to blood CLefflux,peripheral (L/min) 0.00517
(0.00434–0.00708)
0.00418
(0.00311–0.00555)
−0.000980
[−0.00175, −0.000356]
0.004*
Central volume of distribution Vcentral (L) 11.1
(9.55–12.5)
6.32
(5.69–9.69)
−4.42
[−5.54, −3.24]
<0.0001*
Volume of distribution in the liver Vliver (L) 0.958
(0.527–1.39)
0.891
(0.648–1.43)
−0.0424
[−0.355, 0.225]
0.913

Data presented as median (range). Median difference with 95% confidence interval (by Hodges-Lehmann estimation). Mann-Whitney-Wilcoxon test, NASH vs. healthy,

*

p<0.05